These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16219926)

  • 1. Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study.
    Nieboer P; Buijs C; Rodenhuis S; Seynaeve C; Beex LV; van der Wall E; Richel DJ; Nooij MA; Voest EE; Hupperets P; Mulder NH; van der Graaf WT; TenVergert EM; van Tinteren H; de Vries EG
    J Clin Oncol; 2005 Nov; 23(33):8296-304. PubMed ID: 16219926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life.
    Buijs C; Rodenhuis S; Seynaeve CM; van Hoesel QG; van der Wall E; Smit WJ; Nooij MA; Voest E; Hupperets P; TenVergert EM; van Tinteren H; Willemse PH; Mourits MJ; Aaronson NK; Post WJ; de Vries EG
    J Clin Oncol; 2007 Dec; 25(34):5403-9. PubMed ID: 18048822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors.
    Schultz PN; Klein MJ; Beck ML; Stava C; Sellin RV
    J Clin Nurs; 2005 Feb; 14(2):204-11. PubMed ID: 15669929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
    Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
    Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
    Fan HG; Houédé-Tchen N; Yi QL; Chemerynsky I; Downie FP; Sabate K; Tannock IF
    J Clin Oncol; 2005 Nov; 23(31):8025-32. PubMed ID: 16258100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
    Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.
    Tchen N; Juffs HG; Downie FP; Yi QL; Hu H; Chemerynsky I; Clemons M; Crump M; Goss PE; Warr D; Tweedale ME; Tannock IF
    J Clin Oncol; 2003 Nov; 21(22):4175-83. PubMed ID: 14615445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors related to post-treatment chronic pain in breast cancer survivors: the interference of pain with life functions.
    Gulluoglu BM; Cingi A; Cakir T; Gercek A; Barlas A; Eti Z
    Int J Fertil Womens Med; 2006; 51(2):75-82. PubMed ID: 16881383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in patients with testicular cancer: a comparative analysis according to therapeutic modalities.
    Miyake H; Muramaki M; Eto H; Kamidono S; Hara I
    Oncol Rep; 2004 Oct; 12(4):867-70. PubMed ID: 15375514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.
    Venturini M; Del Mastro L; Aitini E; Baldini E; Caroti C; Contu A; Testore F; Brema F; Pronzato P; Cavazzini G; Sertoli MR; Canavese G; Rosso R; Bruzzi P
    J Natl Cancer Inst; 2005 Dec; 97(23):1724-33. PubMed ID: 16333028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.
    Aapro M; Leonard RC; Barnadas A; Marangolo M; Untch M; Malamos N; Mayordomo J; Reichert D; Pedrini JL; Ukarma L; Scherhag A; Burger HU
    J Clin Oncol; 2008 Feb; 26(4):592-8. PubMed ID: 18235117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective assessment of fatigue and health status in Greek patients with breast cancer undergoing adjuvant radiotherapy.
    Lavdaniti M; Patiraki E; Dafni U; Katapodi M; Papathanasoglou E; Sotiropoulou A
    Oncol Nurs Forum; 2006 May; 33(3):603-10. PubMed ID: 16676016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life after chemotherapy for advanced germ cell tumors: a comparison of standard-dose and high-dose chemotherapy.
    Miyake H; Muramaki M; Eto H; Kamidono S; Hara I
    Int J Urol; 2004 Jul; 11(7):542-6. PubMed ID: 15242365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of fatigue during and following adjuvant breast cancer chemotherapy: a pilot study.
    Berger AM; Higginbotham P
    Oncol Nurs Forum; 2000 Oct; 27(9):1443-8. PubMed ID: 11058976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.
    Muss HB; Tu D; Ingle JN; Martino S; Robert NJ; Pater JL; Whelan TJ; Palmer MJ; Piccart MJ; Shepherd LE; Pritchard KI; He Z; Goss PE
    J Clin Oncol; 2008 Apr; 26(12):1956-64. PubMed ID: 18332474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptom clusters and their effect on the functional status of patients with cancer.
    Dodd MJ; Miaskowski C; Paul SM
    Oncol Nurs Forum; 2001 Apr; 28(3):465-70. PubMed ID: 11338755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: a multicenter study.
    So WK; Marsh G; Ling WM; Leung FY; Lo JC; Yeung M; Li GK
    Oncol Nurs Forum; 2009 Jul; 36(4):E205-14. PubMed ID: 19581224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life.
    Byar KL; Berger AM; Bakken SL; Cetak MA
    Oncol Nurs Forum; 2006 Jan; 33(1):E18-26. PubMed ID: 16470230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.
    Ganz PA; Hussey MA; Moinpour CM; Unger JM; Hutchins LF; Dakhil SR; Giguere JK; Goodwin JW; Martino S; Albain KS
    J Clin Oncol; 2008 Mar; 26(8):1223-30. PubMed ID: 18227530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of physical activity on cardiorespiratory fitness and health-related quality of life in young and middle-aged cancer patients shortly after chemotherapy.
    Thorsen L; Skovlund E; Strømme SB; Hornslien K; Dahl AA; Fosså SD
    J Clin Oncol; 2005 Apr; 23(10):2378-88. PubMed ID: 15800330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.